Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $127.84 and last traded at $125.7360, with a volume of 137,843 shares traded. The stock had previously closed at $126.55.
The company reported $1.83 EPS for the quarter, beating analysts’ consensus estimates of $1.79 by $0.04. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%. The firm had revenue of $387.74 million for the quarter, compared to analysts’ expectations of $388.72 million. During the same period last year, the firm earned $1.56 EPS. The company’s quarterly revenue was up 7.0% on a year-over-year basis.
Analyst Upgrades and Downgrades
Several research analysts have commented on ADUS shares. Bank of America lowered Addus HomeCare from a “buy” rating to a “neutral” rating and cut their price target for the stock from $140.00 to $125.00 in a research report on Monday, September 14th. Raymond James Financial set a $137.00 price target on shares of Addus HomeCare in a report on Monday, September 28th. Royal Bank Of Canada upped their price objective on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Barclays boosted their price objective on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research note on Wednesday, July 8th. Finally, Citigroup lowered Addus HomeCare from a “market outperform” rating to a “neutral” rating in a research report on Monday, September 14th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $129.33.
Get Our Latest Research Report on ADUS
Hedge Funds Weigh In On Addus HomeCare
A number of large investors have recently made changes to their positions in the business. NFJ Investment Group LLC bought a new position in shares of Addus HomeCare in the second quarter valued at approximately $29,000. Parallel Advisors LLC grew its holdings in shares of Addus HomeCare by 66.3% during the 1st quarter. Parallel Advisors LLC now owns 404 shares of the company’s stock worth $38,000 after purchasing an additional 161 shares in the last quarter. Heritage Family Offices LLP bought a new stake in Addus HomeCare in the 3rd quarter valued at $43,000. State of Wyoming bought a new position in Addus HomeCare during the second quarter worth about $79,000. Finally, Nisa Investment Advisors LLC grew its position in Addus HomeCare by 16.9% in the third quarter. Nisa Investment Advisors LLC now owns 769 shares of the company’s stock valued at $85,000 after acquiring an additional 111 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.
Addus HomeCare Stock Down 0.1%
The stock has a market capitalization of $2.36 billion, a P/E ratio of 22.17, a P/E/G ratio of 1.79 and a beta of 0.75. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05. The firm’s fifty day moving average is $117.22 and its 200-day moving average is $106.62.
Addus HomeCare Company Profile
Addus HomeCare Inc (NASDAQ: ADUS) provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.
The company’s personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.
Read More
- Five stocks we like better than Addus HomeCare
- Bloom Energy: The Off-Grid Answer to AI’s Power Drain
- Space Race 2.0: Intuitive Machines Secures Another NASA Contract
- Zebra Technologies’ Sell-Off: 3 Factors Investors May Be Missing
- Advanced Micro Devices’ Q3 Results Answer a Big Question, But Another Remains
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
